Market Overview The CD47 antibody market is experiencing growth as this immune checkpoint target enables cancer immunotherapy through blockade of the "don't eat me" signal. The global market is projected to exceed USD 4.8 billion through 2030, driven by cancer immunotherapy advancement, combination therapy development, and clinical trial expansion. CD47 antibodies enable immunotherapy through...